We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
1901
DELISTED
Hanger Inc.
HNGR
| $2.04M | ﹤0.01% |
92,713
-16,482
| -15% | -$382K |
|
|
ANAT
1902
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.03M | ﹤0.01% |
10,753
+433
| +4% | +$77K |
|
|
TVRD
1903
Tvardi Therapeutics
TVRD
$23.4M
| $2.02M | ﹤0.01% |
3,637
-497
| -12% | -$249K |
|
|
ABTX
1904
DELISTED
Allegiance Bancshares
ABTX
| $2M | ﹤0.01% |
52,553
-6,293
| -11% | -$231K |
|
|
ARCH
1905
DELISTED
Arch Resources, Inc.
ARCH
| $2M | ﹤0.01% |
21,505
+495
| +2% | +$34.8K |
|
1906
Cimpress
CMPR
$2.31B
| $1.99M | ﹤0.01% |
22,966
+293
| +1% | +$28.7K |
|
1907
QuinStreet
QNST
$1.21B
| $1.99M | ﹤0.01% |
113,280
-18,207
| -14% | -$327K |
|
|
ZUO
1908
DELISTED
Zuora, Inc.
ZUO
| $1.99M | ﹤0.01% |
119,926
+5,128
| +4% | +$86.4K |
|
1909
Golar LNG
GLNG
$5.13B
| $1.98M | ﹤0.01% |
152,881
+4,625
| +3% | +$53.4K |
|
1910
Digi International
DGII
$3.1B
| $1.98M | ﹤0.01% |
94,156
-12,106
| -11% | -$251K |
|
1911
Koppers
KOP
$969M
| $1.97M | ﹤0.01% |
63,137
-7,577
| -11% | -$236K |
|
|
SRDX
1912
DELISTED
Surmodics
SRDX
| $1.97M | ﹤0.01% |
35,500
-5,509
| -13% | -$306K |
|
1913
Comtech Telecommunications
CMTL
$51.8M
| $1.97M | ﹤0.01% |
76,909
-9,904
| -11% | -$249K |
|
1914
Virtu Financial
VIRT
$4.93B
| $1.97M | ﹤0.01% |
80,595
-6,447
| -7% | -$164K |
|
|
BRSP
1915
BrightSpire Capital
BRSP
$648M
| $1.97M | ﹤0.01% |
209,555
+3,548
| +2% | +$34.3K |
|
1916
Movado Group
MOV
$841M
| $1.97M | ﹤0.01% |
62,447
-5,572
| -8% | -$178K |
|
1917
Bristow Group
VTOL
$1.36B
| $1.97M | ﹤0.01% |
61,738
+9,742
| +19% | +$284K |
|
1918
HCI Group
HCI
$2.41B
| $1.95M | ﹤0.01% |
17,638
-2,468
| -12% | -$257K |
|
1919
Kymera Therapeutics
KYMR
$8.94B
| $1.95M | ﹤0.01% |
33,253
+5,696
| +21% | +$330K |
|
|
CNSL
1920
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.95M | ﹤0.01% |
212,516
-29,420
| -12% | -$262K |
|
|
OCDX
1921
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $1.95M | ﹤0.01% |
105,471
+15,429
| +17% | +$311K |
|
1922
Relay Therapeutics
RLAY
$4.33B
| $1.95M | ﹤0.01% |
61,741
+2,876
| +5% | +$96.8K |
|
1923
Universal Electronics
UEIC
$61.3M
| $1.94M | ﹤0.01% |
39,439
-6,455
| -14% | -$313K |
|
1924
PDF Solutions
PDFS
$2.07B
| $1.94M | ﹤0.01% |
84,226
-10,033
| -11% | -$207K |
|
1925
Century Aluminum
CENX
$5.07B
| $1.94M | ﹤0.01% |
144,108
-19,585
| -12% | -$246K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.